[{"link_title3":"citrusoncology.com ","profilepic":"/images/professional-headshot.jpg","body":"Dr. Afreen Shariff is an Endocrinologist, the Co-founder of Citrus Oncology and an Associate Professor of Medicine at the Duke University School of Medicine. Her clinical and research focus is in improving care for endocrine disorders in cancer patients. \n\nShe has a profound commitment to enhancing healthcare delivery and equity through value-based, patient-centric clinical and educational programs targeted at improving access and reducing health costs while managing complex oncology patients effectively. \n\nWith the mission to provide cancer warriors with incident and existing side effects from cancer drugs, the highest quality care through innovation, collaboration and compassion, Dr. Shariff has created and led several successful initiatives over the years. A few of these include, the Duke Endo Oncology Program, Cancer Therapy Toxicity Program, founding the Onco-Endocrinology Special Interest Group (SIG) through The Endocrine Society and creating a novel AI model to effectively predict hospitalizations from immunotherapy related adverse events up to 2 weeks in advance of the expected event. She is the recipient of the 2023 ACCC Innovator Award and Healio Disruptive Innovator Award 2024 for Clinical Innovation. In 2024, she Co-founded a virtual multi-specialty cancer support clinic- Citrus Oncology that enables patients and oncologists to take control of side effects from cancer drugs from the comfort of their home or offices. Visit citrusoncology.com for more information. \n\nTimely access, patient-provider-subspecialist education, care navigation and predicting and preventing hospital admissions from toxicities using AI powered clinical decision tools has been the focus of her career.  \n\nDr. Shariff decided to leverage the impact and outreach of podcasts as a medium to advance her educational mission and started Checkpoint NOW in 2020. \n","name":"Afreen Idris Shariff, MD","order":1,"link_title":"Profile","link2":"https://twitter.com/afreenshariffmd","link3":"http://www.dukecancerinstitute.org/topics/afreen-shariff","link":"https://scholars.duke.edu/person/afreen.shariff","link_title2":"Twitter"},{"body":"Dr. Funchain is a medical oncologist specializing in melanoma, high risk skin cancers, immunotherapy toxicities, and hereditary cancer genetics. She started in oncology at the Cleveland Clinic, where she served as Director of both Melanoma Oncology and Cancer Genomics. In Cleveland, she developed and led the first irAE tumor board established in the US in 2017 and launched the Management of Checkpoint Inhibitor-Related Toxicity conference in 2020, the longest running clinical care and research conference on irAEs. She moved with her family to Stanford Cancer in 2023. At Stanford, Dr. Funchain codirects the Immunotherapy Toxicity (IOTOX) Working Group as well as the Skin Cancer Genomics Program. Nationally, Dr. Funchain co-chaired the inaugural American Society of Clinical Oncology (ASCO) Guidelines Panel on Systemic Therapy in Melanoma and serves on the ASCO Guidelines Panel on the Management of irAEs. Dr Funchain joins the Checkpoint NOW podcast in 2024 to continue the conversation on irAE management and research with the greater community of patients and medical providers. ","link":"https://med.stanford.edu/profiles/pauline-funchain","profilepic":"/images/funchain-pauline_12_v2_sq.jpg","name":"Pauline Funchain, MD","order":2,"link_title":"Professional Appointment","link2":"@FunchainMD"},{"order":3,"name":"Tian Zhang, MD, MHS (Former Host)","body":"Tian Zhang, M.D., M.H.S., is an Associate Professor in the Department of Internal Medicine at UT Southwestern Medical Center. She specializes in the diagnosis and treatment of genitourinary malignancies, including kidney, prostate, bladder, and testicular cancers.\n\nDr. Zhang earned her medical degree from the Harvard-MIT Health Sciences and Technology (HST) program at Harvard Medical School. She completed a residency in internal medicine at Duke University, where she also received advanced training through a hematology-oncology fellowship. In addition, she earned a Master of Health Sciences in the Clinical Research Training Program at Duke in 2019.\n\nCertified by the American Board of Internal Medicine in medical oncology, she joined the UT Southwestern faculty in 2021. Dr. Zhang is a clinical trialist and translational researcher focused on evaluating clinical development of novel therapeutics and evaluating biomarkers for genitourinary malignancies. She partners closely with a multidisciplinary team at UT Southwestern to provide data-driven clinical care for her patients.\n\nShe has gained an international reputation developing clinical trials in kidney, prostate, and bladder cancers. She serves as the study chair for PDIGREE, a phase III trial in metastatic renal cell carcinoma.\n\nDr. Zhang is a member of several professional organizations, including the American Society of Clinical Oncology (ASCO), the American Association for Cancer Research (AACR), and the European Society for Medical Oncology (ESMO).\n\nShe serves on numerous committees, including as Co-chair of the National Cancer Institute Genitourinary (GU) Steering Committee Renal Task Force and as Chair of the Chinese American Hematologist and Oncologist Network (CAHON) Academic Committee. She is a member of several ASCO clinical management guidelines committees as well as the Alliance for Clinical Trials in Oncology, GU Oncology, and Immuno-Oncology Committees.\n\nShe brings a track record of research and mentoring to UT Southwestern. She has received multiple peer-reviewed grants, a Resident Research Mentoring Award from Duke, and, notably, the 2021 Cancer Prevention & Research Institute of Texas (CPRIT) Scholar Rising Stars Award.\n\nDr. Zhang was the co-host of Checkpoint NOW since its inception in 2020 till 2024. She was instrumental in creating the formative impact of the podcast and continues to be a great support and resource for Checkpoint NOW!","link":"https://utswmed.org/doctors/tian-zhang/","link_title":"Website","link2":"@TiansterZhang","link_title2":"X","profilepic":"/images/tian-zhang-md.jpg"}]